- Home
- FMS vs ICLR Comparison
FMS vs ICLR Comparison
Compare FMS & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FMS | ICLR |
|---|---|---|
| Founded | 1996 | 1990 |
| Country | Germany | Ireland |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 14.3B |
| IPO Year | 1996 | 1998 |
Fundamental Metrics
Financial Performance| Metric | FMS | ICLR |
|---|---|---|
| Price | $23.28 | $185.88 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 14 |
| Target Price | $30.00 | ★ $201.23 |
| AVG Volume (30 Days) | 482.1K | ★ 1.0M |
| Earning Date | 11-04-2025 | 10-22-2025 |
| Dividend Yield | ★ 2.45% | N/A |
| EPS Growth | ★ 8.62 | N/A |
| EPS | 2.86 | ★ 7.47 |
| Revenue | ★ $23,046,819,198.00 | $8,102,602,000.00 |
| Revenue This Year | $2.12 | N/A |
| Revenue Next Year | $2.92 | $0.76 |
| P/E Ratio | ★ $15.86 | $24.87 |
| Revenue Growth | ★ 2.10 | N/A |
| 52 Week Low | $22.05 | $125.10 |
| 52 Week High | $30.46 | $228.29 |
Technical Indicators
Market Signals| Indicator | FMS | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 37.10 | 62.18 |
| Support Level | $22.51 | $174.13 |
| Resistance Level | $24.20 | $191.15 |
| Average True Range (ATR) | 0.30 | 8.46 |
| MACD | 0.09 | 2.87 |
| Stochastic Oscillator | 45.27 | 85.77 |
Price Performance
Historical ComparisonAbout FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.